Analysts See $0.51 EPS for Owens & Minor, Inc. (OMI)

January 20, 2018 - By Stephen Andrade

 Analysts See $0.51 EPS for Owens & Minor, Inc. (OMI)
Investors sentiment increased to 1.47 in Q3 2017. Its up 0.01, from 1.46 in 2017Q2. It increased, as 29 investors sold Owens & Minor, Inc. shares while 62 reduced holdings. 33 funds opened positions while 101 raised stakes. 57.73 million shares or 2.27% less from 59.07 million shares in 2017Q2 were reported.
Bessemer has invested 0.01% in Owens & Minor, Inc. (NYSE:OMI). Vanguard Inc owns 5.70M shares or 0.01% of their US portfolio. Mackenzie holds 1.34M shares. Neuberger Berman Group Inc Ltd Liability reported 7,740 shares. Comml Bank Of Montreal Can reported 43,171 shares. Ghp Investment Advsrs invested 0.19% of its portfolio in Owens & Minor, Inc. (NYSE:OMI). First Manhattan Com holds 749 shares. 79,069 were reported by Commonwealth Equity Svcs Inc. Legal And General Group Inc Public Ltd Liability Corporation reported 0% stake. New York State Teachers Retirement reported 131,185 shares. Northwestern Mutual Wealth Management Co stated it has 0% in Owens & Minor, Inc. (NYSE:OMI). California State Teachers Retirement Systems owns 0.01% invested in Owens & Minor, Inc. (NYSE:OMI) for 103,000 shares. Cwm Ltd stated it has 816,743 shares. Dean Invest Assoc Llc holds 0.57% of its portfolio in Owens & Minor, Inc. (NYSE:OMI) for 127,380 shares. Foster And Motley Inc reported 0.12% stake.

Analysts expect Owens & Minor, Inc. (NYSE:OMI) to report $0.51 EPS on February, 13.They anticipate $0.01 EPS change or 1.92 % from last quarter’s $0.52 EPS. OMI’s profit would be $31.25M giving it 10.52 P/E if the $0.51 EPS is correct. After having $0.40 EPS previously, Owens & Minor, Inc.’s analysts see 27.50 % EPS growth. The stock increased 1.27% or $0.27 during the last trading session, reaching $21.46. About 1.24 million shares traded. Owens & Minor, Inc. (NYSE:OMI) has declined 11.64% since January 20, 2017 and is downtrending. It has underperformed by 28.34% the S&P500.

Owens & Minor, Inc. (NYSE:OMI) Ratings Coverage

Among 9 analysts covering Owens & Minor (NYSE:OMI), 0 have Buy rating, 5 Sell and 4 Hold. Therefore 0 are positive. Owens & Minor has $37 highest and $17 lowest target. $25.67’s average target is 19.62% above currents $21.46 stock price. Owens & Minor had 15 analyst reports since August 25, 2015 according to SRatingsIntel. Robert W. Baird maintained it with “Hold” rating and $24.0 target in Wednesday, January 17 report. The firm has “Underperform” rating given on Monday, November 7 by Bank of America. The rating was downgraded by JP Morgan on Tuesday, December 19 to “Underweight”. On Tuesday, December 19 the stock rating was downgraded by J.P. Morgan to “Sell”. Jefferies maintained Owens & Minor, Inc. (NYSE:OMI) on Monday, September 11 with “Hold” rating. The rating was downgraded by Robert W. Baird on Thursday, April 21 to “Underperform”. The rating was maintained by RBC Capital Markets with “Sector Perform” on Monday, December 7. The stock has “Hold” rating by Leerink Swann on Thursday, November 2. The stock has “Neutral” rating by Robert W. Baird on Friday, September 1. The company was downgraded on Tuesday, August 25 by Zacks.

Owens & Minor, Inc., together with its subsidiaries, operates as a healthcare services firm in the United States, the United Kingdom, Ireland, France, Germany, and other European countries. The company has market cap of $1.32 billion. The firm operates through three divisions: Domestic, International, and Clinical & Procedural Solutions. It has a 17 P/E ratio. It offers supply chain assistance to the providers of healthcare services; and the manufacturers of healthcare products, supplies, and devices.

More news for Owens & Minor, Inc. (NYSE:OMI) were recently published by: Seekingalpha.com, which released: “‘Mini-Crat’ Profile: Owens & Minor Is Cheap With A Safe 4.99% Dividend” on January 15, 2018. Seekingalpha.com‘s article titled: “Bed Pans To Bariatric Chairs: Owens & Minor Has It All” and published on January 14, 2018 is yet another important article.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter: